Peter Foster Bross, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

George Washington University School Of Medicine And Health Sciences - Washington DC
Rank: Instructor
Years: 2005 - present

George Washington University School Of Medicine And Health Sciences - Washington DC
Rank: Instructor
Years: 2005-present

None Reported

Empiric antimicrobial therapy of febrile neutropenic patients undergoing hematopoetic stem cell transplantation.
International Journal of Antimicrobial Agents
13: 127-130
Date: 01 1999

Approval Summary: Gemtuzumab Ozogamicin in Relapsed Acute Myeloid Leukemia
Clinical Cancer Research
Volume: 7
Date: 06 2001
clincancerres.aacrjournals.org/

Approval Summary for bortezomib for injection in the treatment of multiple myeloma.
Clincal Cancer Research
Volume: 10
Date: 01 2005

FDA and industry dialog at the 4th FDA/DIA/PhRMA/PWG/BIO Pharmacogenomics Workshop
Pharmacogenomics
Volume: 10
Date: 01 2009

Regulation of immunotherapeutic products for cancer and FDA's role in product development and clinical evaluation.
J Immunother Cancer.
Volume: 1
Date: 05 2013
www.ncbi.nlm.nih.gov/pmc/articles/PMC3986979/

Regulation of biologic oncology products in the FDA׳s Center for Biologics Evaluation and Research
Urologic Oncology
Volume: 33
Date: 03 2015

Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration2
European Journal of Cancer
Volume: 10
Date: 09 2021
www.ejcancer.com